• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Pantoprazole
    4 Drugs classified under this active ingredient

    All the Active Ingredient Drugs

    Controloc 20
    not in the basket chart
    Controloc 20

    PPI. Pantoprazole 20 mg.
    E.C. TABS: 30. Adult. & adolesc. 12 yrs. of
    age and above: Reflux dis. and assoc.
    symp. (e.g. heartburn, acid
    regurgitation, pain on swallowi.)-
    20mg×1/d. Symp. relief is gener.
    accompl. within 2-4 wks. If this is not
    suffic., symp. relief will normal. be
    achieved within a further 4 wks. When
    symp. relief has been achieved,
    reoccurring symp. can be control. using
    an on-demand regimen of 20mg×1/d,
    taking one tab. when requir.
    Long-term manag.& preven. of relapse
    in reflux esophag.: Mainten. dose- is 20
    mg×1/d is recomm., incr. to 40 mg ×1/d
    if a relapse occurs.After heal. of the
    relapse the dose can be reduced again
    to 20 mg.
    Adults: Preven. of gastroduod. ulc.
    induced by NSAIDs in pts. at risk with a
    need for contin. NSAID tmt.:
    Tmt. of reflux esophagitis & assoc. symp.
    (e.g. heartburn, acid regurgitation, pain
    on swallow.). For long-term manag. &
    prevent. of relapse in reflux esophagitis.
    Preven. of gastroduodenal ulc. induced
    by NSAIDs in pts. at risk with a need for
    continuous NSAIDs tmt.
    C/I: Hypersens., subst. benzimidazoles. Comb. ther. for the eradication of H. pylori in pts. with renal impair. or severe hep. impair.

    Controloc 40
    not in the basket chart
    Controloc 40

    PPI. Pantoprazole 40 mg.
    E.C. TABS: 14, 28. Tmt. mod-severe
    GERD: Adults/adolesc. 12 yrs and
    above: 1 tab x dly. Erad. H. pylori in
    comb. with 2 approp. antibiotics:
    Adults: Depend. On resist. pattern: a) 2
    x dly: 1 x 40 mg +1,000 mg amoxillin +
    500 mg clarithromycin; b) 2 x dly: 1 x
    40 mg + 500 mg metronidazole + 500
    mg clarithromycin; c) 2 x dly: 1 x 40 mg
    + 1,000 mg amoxicillin + 500 mg
    metronidazole. If comb. ther. not an
    option: Monother. as follows: Tmt.
    gastric/duod. ulc: 1 tab dly.
    Zollinger-Ellison syndr. + other
    hypersecret. conds: Long-term
    manage: Initial: 80 mg dly. Can titrate
    up/ down as reqd. Doses above 80 mg
    dly to be div. into 2 doses.
    Pts. with hep. impair.: dly. dose of 20
    mg exceed. in pts. with sev. hep.
    impair, must not be used in comb. tmt.
    For eradic. H. pylori in pts. with moder.
    – sev. hep. dysfunc. since curren. no
    data are availab. on the effic. & safety
    of Pantoprazole in comb. tmt. of these
    Short term tmt. of acute duod. ulcer,
    acute gastric ulcer, mod./sev. reflux
    esophagi., eradic. of H. pylori in comb.
    With clarithromycin and amoxycillin
    orclarithromycin and metronidazole or
    amoxicillin and metronidazole in cases of
    duoden. ulcer & gastric ulcer with the
    object. of reduc. of duod./gastr.ulc.
    caused by this microorganism, Zollinger
    Ellison Syndr.
    C/I: Hypersens., subst. benzimidazoles .
    Comb. ther. for the eradication of H.
    pylori in pts. with renal impair. or severe
    hep. impair..

    Controloc I.V.
    not in the basket chart
    Controloc I.V.

    PPI. Pantoprazole (as sodium) 40 mg/vial.
    VIAL: 1. Duodenal ulcer, gastric ulc., moderate and severe reflux oesophagitis: 40 mg (1 vial) ×1/d.
    Zollinger-Ellison-Syndr.: For the long-term manag. of Zollinger-Ellison-Syndr. pts. should start their tmt. with a dly. dose of 80 mg. Thereafter, the dose can be titrated up or down as needed using measurements of gastric acid secret. to guide. With doses above 80 mg dly., the dose should be divided and given twice dly. A temporary incr. of the dose above 160 mg  is possible but should not be applied longer than requir. for adequate. acid control.
    In case a rapid acid control is requir, a start. dose of 80 mg×2/d. is suffic. to manage a decrease of acid output into the target range (<10 mEq/h) within 1h in the majority of pts.
    Duodenal ulcer. Gastric ulcer. Moderate and severe reflux oesophagitis. Zollinger-Ellison-Syndrome.
    C/I: Hypersens. to the active subst., substitut. benzimidazoles and any of the excipients.

    Pantoavenir IV
    not in the basket chart
    Pantoavenir IV

    PPI. Pantoprazole (as sodium) 40 mg/vial.
    VIAL (pwdr. for inject.): 1, 20. I.V. admin. only if oral admin. not appropriate. Duoden. ulcer, gastric ulcer, mod., severe reflux
    esophagit: 40 mg dly. Long term manage
    Zollinger-Ellison Syndr./other path.
    hypersecret. conds: Initial: 80 mg dly.
    Titrate up/down as req. Above 80 mg, div.
    into 2 dly doses. See lit. Replace I.V.
    formula by oral formula when clin.
    Duoden./gastric ulc., mod., severe reflux
    esophagit., Zollinger-Ellison Syndr., other
    path. hypersecret. conds.
    C/I: Hypersens., co-admin. with atzanavir